BCIQ Profiles

Company Profile Report
1104 Trax
BioCentury & Getty Images

Management Tracks

Rosén joins Horizon as CSO and R&D head; plus moves at Boehringer, Dr. Reddy’s, Mylan and more

Nov 5, 2020 | 1:56 AM GMT

Karin Rosén joined Horizon Therapeutics plc (NASDAQ:HZNP) as CSO and EVP, research and development. She was SVP, U.S. medical affairs at GlaxoSmithKline plc (LSE:GSK; NYSE:GSK).


Read the full 512 word article

How to gain access

Continue reading with a
two-week free trial.